Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac ECM and Index Rebal

CATL (300750 CH): Tactical Outlook After Discounted Share Placement Announcement

CATL H-Share (3750 HK) Placement Dip Opens Put-Underwriting Setup

CATL (3750HK / 3000750 CH): Long-Term Compounder Proving Market Dominance

Aequitas: CATL H-Share Placement- Will Be Very Well Flagged US$5bn Deal but Last Deal Didn’t Do Well

Aequitas: CATL H-Share Placement - Has Seen Nearly US$5bn Worth of Wrong Deals

Aequitas ECM Weekly (20 April 2026)-CATL, Victory Giant, Sigenergy, Gpixel, Huaqin, MTT, JST

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Index Rebalance

Contemporary Amperex Technology / Index Rebalance

Contemporary Amperex Technology (3750 HK)

<ul>
<li>We assess the HSI and HSCEI index impact of CATL's 62.4m primary share placement across four review cycles to May 2027.</li>
<li>HSI weight rises toward 0.8–0.9% at the Sep 2026 rebalance; HSCEI inclusion likely by Feb 2027 as post-placement shares dominate the MV12 window.</li>
<li>Two passive flow events totalling 5.36m shares for HSI and HSCEI will happen over two implementation cycles.</li>
</ul>


We assess the HSI and HSCEI index impact of CATL's 62.4m primary share placement across four review cycles to May 2027.
HSI weight rises toward 0.8–0.9% at the Sep 2026 rebalance; HSCEI inclusion likely by Feb 2027 as post-placement shares dominate the MV12 window.
Two passive flow events totalling 5.36m shares for HSI and HSCEI will happen over two implementation cycles.


Contemporary Amperex Technology (CATL) (300750 CH)

CATL-H Placement: HSI and HSCEI Index Impact